F-star Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$10.1M

310 transactions

Summary

F-star Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.5MSales: $64K22 insiders

Date	Insider	Type	Value
2023-03-08	Brewis Neil(CHIEF SCIENTIFIC OFFICER)	U	$748K
2023-03-08	Bermingham Nessan	U	$695K
2023-03-08	Brewis Neil(CHIEF SCIENTIFIC OFFICER)	D	$67K
2023-03-08	Arkowitz David	U	$60K
2023-03-08	Bermingham Nessan	D	$45K
2023-03-08	Benz Edward JR	D	$31K
2023-03-08	Race Geoffrey	U	$28K
2023-03-08	Arkowitz David	D	—
2023-03-08	Arkowitz David	D	—
2023-03-08	Benz Edward JR	D	—
2023-03-08	Benz Edward JR	D	—
2023-03-08	Benz Edward JR	D	—
2023-03-08	Bermingham Nessan	D	—
2023-03-08	Bermingham Nessan	D	—
2023-03-08	Bermingham Nessan	D	—
2023-03-08	Race Geoffrey	D	—
2023-03-08	Race Geoffrey	D	—
2023-03-08	Brewis Neil(CHIEF SCIENTIFIC OFFICER)	D	—
2023-03-08	Brewis Neil(CHIEF SCIENTIFIC OFFICER)	D	—
2023-03-08	Brewis Neil(CHIEF SCIENTIFIC OFFICER)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

F-star Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope